Scientific Opinion on the substantiation of health claims related to almonds and maintenance of normal blood LDL cholesterol concentrations (ID 1131) and maintenance of normal erectile function (ID 2482) pursuant to Article 13(1) of Regulation (EC) No 1924/2006

Documenti analoghi

• Scientific Opinion on the substantiation of health claims related to rapeseed oil and maintenance of normal blood LDL‐cholesterol concentrations (ID 580, 581, 1408) and maintenance of normal blood HDL‐cholesterol concentrations (ID 1408) pursuant to Article 13(1) of Regulation (EC) No 1924/2006
  di: EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA)
  Pubblicazione: (2011-04-01)
• Scientific Opinion on the substantiation of health claims related to almonds and maintenance of normal blood LDL cholesterol concentrations (ID 1131) and maintenance of normal erectile function (ID 2482) pursuant to Article 13(1) of Regulation (EC) No 1924/2006
  di: EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA)
  Pubblicazione: (2011-04-01)
• Scientific Opinion on the substantiation of health claims related to resistant maltodextrin and reduction of post prandial glycaemic responses (ID 796), maintenance of normal blood LDL cholesterol concentrations (ID 2927), maintenance of normal (fasting) blood concentrations of triglycerides (ID 2927) and changes in bowel function (ID 797) pursuant to Article 13(1) of Regulation (EC) No 1924/2006
  di: EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA)
  Pubblicazione: (2011-04-01)
• Scientific Opinion on the substantiation of health claims related to sugar beet fibre and reduction of post‐prandial glycaemic responses (ID 752), maintenance of normal blood glucose concentrations (ID 752), maintenance of normal blood LDL cholesterol concentrations (ID 809), and changes in bowel function (ID 751) pursuant to Article 13(1) of Regulation (EC) No 1924/2006
  di: EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA)
  Pubblicazione: (2011-04-01)
• Scientific Opinion on the substantiation of health claims related to gamma linolenic acid (GLA) and maintenance of normal blood LDL cholesterol concentrations (ID 2661, 4452, 4453), maintenance of normal blood pressure (ID 2662), reduction of menstrual discomfort (ID 495, 640, 1773, 1775), contribution to normal cognitive function (ID 1770), maintenance of the barrier function of the skin (ID 499, 591, 639, 676, 1554, 2003, 2065), “function of the cell membrane” (ID 1769), maintenance of normal structure, elasticity and appearance of the skin (ID 2660, 4296), and “anti‐inflammatory properties” (ID 4454) pursuant to Article 13(1) of Regulation (EC) No 1924/2006
  di: EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA)
  Pubblicazione: (2011-04-01)